Hauck & Aufhaeuser Reiterates €55.00 Price Target for Gerresheimer (GXI)
Gerresheimer (ETR:GXI) has been assigned a €55.00 ($67.90) price target by stock analysts at Hauck & Aufhaeuser in a research note issued on Tuesday. The brokerage presently has a “sell” rating on the stock. Hauck & Aufhaeuser’s target price points to a potential downside of 17.23% from the stock’s current price.
Several other equities research analysts have also commented on the company. Berenberg Bank set a €75.00 ($92.59) price objective on Gerresheimer and gave the stock a “buy” rating in a research note on Friday, December 8th. Deutsche Bank set a €64.00 ($79.01) price objective on Gerresheimer and gave the stock a “neutral” rating in a research note on Thursday, October 12th. Credit Suisse Group set a €80.00 ($98.77) price objective on Gerresheimer and gave the stock a “buy” rating in a research note on Tuesday, October 10th. Goldman Sachs Group set a €69.50 ($85.80) price objective on Gerresheimer and gave the stock a “neutral” rating in a research note on Thursday, October 12th. Finally, Kepler Capital Markets set a €65.00 ($80.25) price objective on Gerresheimer and gave the stock a “sell” rating in a research note on Friday, November 3rd. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of €71.61 ($88.41).
Gerresheimer (ETR:GXI) opened at €66.45 ($82.04) on Tuesday. Gerresheimer has a 52 week low of €59.97 ($74.04) and a 52 week high of €78.25 ($96.60). The firm has a market capitalization of $2,070.00 and a PE ratio of 47.13.
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.